Increasing investments in biopharmaceutical research are encouraging the development of advanced erythropoietin formulations. Manufacturers are exploring improved drug delivery approaches and production technologies to address changing healthcare requirements.
Market Overview
The Erythropoietin Drug Market was valued at US$ 13.14 billion in 2025 and is projected to reach US$ 29.00 billion by...
